IDSA: Vaccination Less Likely With Increasing Social Vulnerability, Black Race

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 18, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, Oct. 18, 2024 -- Vaccination for influenza, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and respiratory syncytial virus (RSV) is less likely with an increasing social vulnerability index (SVI) and Black race, according to a study presented at the annual meeting of the Infectious Diseases Society of America (IDWeek), held from Oct. 16 to 19 in Los Angeles.

Zainab Albar, M.B.B.S., Ph.D., from Case Western Reserve University in Cleveland, and colleagues analyzed data from patients with acute respiratory infections and examined the connection of SVI and race with vaccination rates for influenza, SARS-CoV-2, and RSV. The cohort included a diverse population of 341,029 individuals (81 percent White).

The researchers found that vaccination rates decreased as the SVI quartile increased, especially among Black individuals. In addition, with higher SVI quartiles, there were increases in emergency visits for acute respiratory infections and decreases in primary care visits. As the SVI quartile increased, the likelihood of vaccination decreased, especially among Black people; Black individuals had lower odds of receiving a flu vaccine in all SVI quartiles. The odds of receiving SARS-CoV-2 and RSV vaccines were also lower for Black versus White individuals in all SVI quartiles.

"Disparities this vast are not to be overlooked -- they require multifaceted interventions that meet people where they are socially and increase access to essential preventive measures," coauthor Elie Saade, M.D., M.P.H., from the University Hospitals of Cleveland, said in a statement.

One author disclosed ties to the pharmaceutical industry.

Press Release

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords